News

Researchers from The University of Texas San Antonio have identified a molecular process that leads to abnormal RNA production in Alzheimer’s disease and a rare brain disorder, progressive supranuclear palsy. The abnormal RNA behaves similarly to inflammatory triggers in viral infections.

NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment.

An research team have been developing a personalized mRNA cancer-treatment vaccine approach. It is designed to help immune cells recognize specific neoantigens on patients’ pancreatic cancer cells.

Researchers at the Beckman Institute for Advanced Science and Technology used deep learning to develop a new framework for super-resolution ultrasound.

Scientists at the University of Queensland have made a breakthrough in understanding how the drug and ubiquitous cosmetic treatment Botox penetrates brain cells. Their study was published in The EMBO Journal.

In two new studies, researchers designed and tested a series of textile fibers that can change shape and generate force like a muscle.

Mount Sinai researchers have published what they say is the first study to identify a new form of treatment for rapid eye movement (REM) sleep behavior disorder.

Data from a Mount Sinai-led phase 3 trial published today in The New England Journal of Medicine show that upadacitinib, a breakthrough, once-daily oral medication, helps patients achieve and maintain clinical and endoscopic remission.

Researchers from Japan have found that a bacterial nanomachine with an unusual cellular location can protect cells from stressful environments.

Word choice matters—a lot— when it comes to research. That's the conclusion of a new study that analyzed HIV-related stigmatizing language published in scientific literature from 2010 to 2020.